166 related articles for article (PubMed ID: 28163005)
1. Letrozole not superior to anastrozole for early breast cancer.
Brower V
Lancet Oncol; 2017 Mar; 18(3):e138. PubMed ID: 28163005
[No Abstract] [Full Text] [Related]
2. Current developments in hormonal therapy of breast cancer.
Buzdar AU
Clin Breast Cancer; 2004 Sep; 5 Suppl 1():S4-5. PubMed ID: 15347432
[No Abstract] [Full Text] [Related]
3. Anastrozole may aid breast cancer prevention.
Cancer Discov; 2014 Feb; 4(2):OF4. PubMed ID: 24501316
[TBL] [Abstract][Full Text] [Related]
4. Remission of macroglobulinemia during anastrozole treatment for breast cancer.
Chettle C; Baker MA
N Engl J Med; 2005 Apr; 352(16):1725-6. PubMed ID: 15843681
[No Abstract] [Full Text] [Related]
5. Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.
Buzdar AU
J Clin Oncol; 2007 May; 25(15):2147-8; author reply 2148. PubMed ID: 17513830
[No Abstract] [Full Text] [Related]
6. The bone substudy of MA.27: does bone make a difference?
Mathew A; Brufsky A
Lancet Oncol; 2014 Apr; 15(4):375-7. PubMed ID: 24636209
[No Abstract] [Full Text] [Related]
7. Adjuvant aromatase inhibitors for breast cancer.
Howell A
Lancet; 2005 Aug 6-12; 366(9484):431-3. PubMed ID: 16084234
[No Abstract] [Full Text] [Related]
8. Aromatase inhibitors come of age.
Dowsett M
Ann Oncol; 1997 Jul; 8(7):631-2. PubMed ID: 9296213
[No Abstract] [Full Text] [Related]
9. Prevention: targeted therapy-anastrozole prevents breast cancer.
Brown P
Nat Rev Clin Oncol; 2014 Mar; 11(3):127-8. PubMed ID: 24535168
[No Abstract] [Full Text] [Related]
10. Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
Hortobagyi GN; Buzdar AU
Cancer Invest; 1998; 16(6):385-90. PubMed ID: 9679529
[No Abstract] [Full Text] [Related]
11. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
Monnier AM
Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
[TBL] [Abstract][Full Text] [Related]
12. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
[No Abstract] [Full Text] [Related]
13. NICE urged to recommend anastrozole for breast cancer prevention.
Wise J
BMJ; 2013 Dec; 347():f7458. PubMed ID: 24336098
[No Abstract] [Full Text] [Related]
14. Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data.
Grana G
J Surg Oncol; 2006 Jun; 93(7):585-92. PubMed ID: 16705732
[TBL] [Abstract][Full Text] [Related]
15. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.
Tobias JS; Howell A
Eur J Cancer; 2004 Aug; 40(12):1913. PubMed ID: 15288295
[No Abstract] [Full Text] [Related]
16. Anastrozole for breast cancer: recent advances and ongoing challenges.
Buzdar AU
Expert Rev Anticancer Ther; 2006 Jun; 6(6):839-48. PubMed ID: 16761927
[TBL] [Abstract][Full Text] [Related]
17. ERBB2 status and outcome of endocrine treatment.
Miller WR
Lancet Oncol; 2008 Jan; 9(1):4-5. PubMed ID: 18177812
[No Abstract] [Full Text] [Related]
18. Anastrozole.
Cuzick J
Drugs Today (Barc); 2005 Apr; 41(4):227-39. PubMed ID: 16034487
[TBL] [Abstract][Full Text] [Related]
19. Letrozole: advancing hormone therapy in breast cancer.
Lee RJ; Armstrong AC; Wardley AM
Womens Health (Lond); 2012 Nov; 8(6):611-8. PubMed ID: 23181527
[TBL] [Abstract][Full Text] [Related]
20. Obesity and hormone therapy in breast cancer: an unfinished puzzle.
Goodwin PJ; Pritchard KI
J Clin Oncol; 2010 Jul; 28(21):3405-7. PubMed ID: 20548001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
